← The Wire
IMANasdaq
ImageneBio, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1835579
Develops therapeutics for immunological, autoimmune, and inflammatory diseases, including its anti-OX40 antibody IMG-007
red 8-K · 90d
$63M
Market cap
$6.07
Last close
+0.8%
1D
+1.3%
5D
8K
Volume
Price · last 39 sessions+6.2%
May 4L $5.25 · H $6.08Jun 29
100
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 26, 20268-KExecutive Change · Shareholder VoteJun 17, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 2026SC 13D/ASC 13D/AApr 29, 2026SC 13DSC 13DApr 21, 20268-KMaterial Agreement · Equity IssuanceApr 13, 20268-KExecutive ChangeMar 17, 202610-K10-KMar 10, 20268-KResults of OperationsMar 10, 20268-KExecutive ChangeFeb 17, 20268-KExecutive ChangeDec 18, 20258-KReg FD DisclosureNov 19, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KExecutive ChangeNov 5, 20258-KMaterial Agreement · Agreement TerminatedOct 29, 20258-KExecutive ChangeOct 22, 20258-KExecutive ChangeOct 10, 2025S-1S-1Sep 8, 20258-K/AAcquisition / DispositionAug 12, 20258-KAuditor ChangeAug 5, 20258-KExecutive Change · Company UpdateAug 1, 20258-KChange of Control · Executive ChangeJul 29, 20258-KReg FD DisclosureJul 25, 202510-Q10-QJul 24, 20258-KCompany UpdateJul 24, 20258-KCompany UpdateJul 22, 20258-KExecutive ChangeJul 16, 20258-KExecutive Change · Shareholder VoteJul 15, 2025425425Jul 11, 20258-KCompany UpdateJul 11, 2025425425Jul 1, 20258-KReg FD Disclosure · Company UpdateJul 1, 202510-Q10-QMay 8, 2025S-4S-4Mar 18, 202510-K10-KMar 6, 2025425425Jan 10, 2025425425Dec 23, 20248-KChange of Control · Executive ChangeDec 23, 2024SC 13GSC 13GNov 14, 202410-Q10-QNov 7, 202410-Q10-QAug 8, 20248-KExecutive ChangeJul 12, 20248-KShareholder VoteJun 10, 20248-KExit / Disposal Costs · Reg FD DisclosureMay 28, 202410-Q10-QMay 13, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 202410-K10-KMar 12, 20248-KExecutive Change · Reg FD DisclosureFeb 21, 20248-KResults of Operations · Exit / Disposal CostsJan 18, 202410-Q10-QNov 9, 20238-KResults of Operations · Company UpdateNov 9, 20238-KShareholder VoteOct 11, 2023DEF 14ADEF 14ASep 25, 2023424B5424B5Sep 12, 202310-Q10-QAug 10, 20238-KMaterial Agreement · Acquisition / DispositionAug 7, 20238-KDelisting NoticeJun 30, 20238-KShareholder VoteJun 9, 20238-KMaterial Agreement · Reg FD DisclosureMay 15, 2023424B5424B5May 15, 202310-Q10-QMay 15, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KReg FD Disclosure · Company UpdateApr 17, 202310-K10-KMar 14, 20238-KExecutive ChangeDec 19, 20228-KReg FD Disclosure · Company UpdateNov 28, 20228-KReg FD Disclosure · Company UpdateNov 10, 202210-Q10-QNov 7, 202210-Q10-QAug 11, 20228-KShareholder VoteJun 10, 202210-Q10-QMay 12, 2022DEFA14ADEFA14AApr 27, 2022DEF 14ADEF 14AApr 27, 20228-KExecutive ChangeApr 13, 2022
Insider Activity
In the 90 days to Dec 24, 2025: 1 insider bought $96K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 24, 2025 | Slattery Joseph PDirector | Buy | 16,000 | $5.99 | $96K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance